Skip to main content
. 2020 Apr 10;12(1):1748322. doi: 10.1080/19420862.2020.1748322

Figure 2.

Figure 2.

Results of the safety assessment from dose escalation PET imaging. The body weights of each group over the 7 d after administration (a). Histograms of liver (b) and spleen (c) uptake after intravenous injection of 89Zr-labeled IBI322. H&E staining of liver and spleen sections from each group. (Scale bar: 200 µm) (d). The black arrow indicates partially necrotic regions of the spleen.